Connect Healthcare Collaboration selects Regenexx as solution to lower employers’ orthopedic surgery costs

Connect Healthcare Collaboration will recommend Regenexx to its employer partners in order to offer alternatives to orthopedic surgery.

Advertisement

Here are three things to know:

1. Connect Healthcare Collaboration works with consultants, brokers and employers to reduce unnecessary healthcare spending while improving plan members’ outcomes.

2. Regenexx is an interventional orthopedic physician network that provides non-surgical stem cell treatments for orthopedic injuries, arthritis and other degenerative conditions.

3. Employers who underwrite Regenexx have reduced their orthopedic healthcare costs by over 80 percent.

More articles on biologics:

Zimmer Biomet to terminate exclusive distribution agreement with BoneSupport: 5 things to know

Medtronic’s Kyphon HV-R Bone Cement receives 2nd indication: 4 key points

ACAP Health partners with Regenexx to reduce orthopedic surgery costs — 3 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.